Application 200678
- Type
- NDA
- Sponsor
- ASTRAZENECA AB
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | KOMBIGLYZE XR | METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 500MG;EQ 5MG BASE | Yes | No |
| 002 | KOMBIGLYZE XR | METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 1GM;EQ 5MG BASE | Yes | Yes |
| 003 | KOMBIGLYZE XR | METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 1GM;EQ 2.5MG BASE | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N200678-001 | KOMBIGLYZE XR | METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE | 500MG;EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-11-05 | |
| N200678-002 | KOMBIGLYZE XR | METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE | 1GM;EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-11-05 | |
| N200678-003 | KOMBIGLYZE XR | METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE | 1GM;EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-11-05 |
Orange Book exclusivity#
| Application-product | Exclusivity code | Expiration |
|---|---|---|
| N200678-001 | M-14 | 2027-10-11 |
| N200678-002 | M-14 | 2027-10-11 |
| N200678-003 | M-14 | 2027-10-11 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N200678-001 | KOMBIGLYZE XR | 500MG;EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-11-05 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N200678-002 | KOMBIGLYZE XR | 1GM;EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-11-05 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N200678-003 | KOMBIGLYZE XR | 1GM;EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-11-05 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N200678-001 | KOMBIGLYZE XR | 500MG;EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-11-05 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N200678-002 | KOMBIGLYZE XR | 1GM;EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-11-05 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N200678-003 | KOMBIGLYZE XR | 1GM;EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-11-05 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N200678-001 | KOMBIGLYZE XR | 500MG;EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-11-05 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N200678-002 | KOMBIGLYZE XR | 1GM;EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-11-05 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N200678-003 | KOMBIGLYZE XR | 1GM;EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-11-05 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N200678-001 | KOMBIGLYZE XR | 500MG;EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-11-05 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N200678-002 | KOMBIGLYZE XR | 1GM;EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-11-05 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N200678-003 | KOMBIGLYZE XR | 1GM;EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-11-05 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N200678-001 | KOMBIGLYZE XR | 500MG;EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-11-05 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N200678-002 | KOMBIGLYZE XR | 1GM;EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-11-05 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N200678-003 | KOMBIGLYZE XR | 1GM;EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-11-05 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N200678-001 | KOMBIGLYZE XR | 500MG;EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-11-05 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N200678-002 | KOMBIGLYZE XR | 1GM;EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-11-05 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N200678-003 | KOMBIGLYZE XR | 1GM;EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-11-05 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N200678-001 | KOMBIGLYZE XR | 500MG;EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-11-05 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N200678-002 | KOMBIGLYZE XR | 1GM;EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-11-05 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N200678-003 | KOMBIGLYZE XR | 1GM;EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-11-05 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N200678-001 | KOMBIGLYZE XR | 500MG;EQ 5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-11-05 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N200678-002 | KOMBIGLYZE XR | 1GM;EQ 5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-11-05 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N200678-003 | KOMBIGLYZE XR | 1GM;EQ 2.5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-11-05 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N200678-001 | KOMBIGLYZE XR | 500MG;EQ 5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-11-05 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N200678-002 | KOMBIGLYZE XR | 1GM;EQ 5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-11-05 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N200678-003 | KOMBIGLYZE XR | 1GM;EQ 2.5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-11-05 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N200678-001 | KOMBIGLYZE XR | 500MG;EQ 5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-11-05 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N200678-002 | KOMBIGLYZE XR | 1GM;EQ 5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-11-05 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N200678-003 | KOMBIGLYZE XR | 1GM;EQ 2.5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-11-05 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N200678-001 | KOMBIGLYZE XR | 500MG;EQ 5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-11-05 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N200678-002 | KOMBIGLYZE XR | 1GM;EQ 5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-11-05 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N200678-003 | KOMBIGLYZE XR | 1GM;EQ 2.5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-11-05 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N200678-001 | KOMBIGLYZE XR | 500MG;EQ 5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-11-05 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N200678-002 | KOMBIGLYZE XR | 1GM;EQ 5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-11-05 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N200678-003 | KOMBIGLYZE XR | 1GM;EQ 2.5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-11-05 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N200678-001 | KOMBIGLYZE XR | 500MG;EQ 5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-11-05 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N200678-002 | KOMBIGLYZE XR | 1GM;EQ 5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-11-05 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N200678-003 | KOMBIGLYZE XR | 1GM;EQ 2.5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-11-05 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N200678-001 | KOMBIGLYZE XR | 500MG;EQ 5MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-11-05 | 1e350fbaab3a… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N200678-001 | AB | 1 | 9b2671bbb829… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N200678-002 | AB | 1 | 9b2671bbb829… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N200678-003 | AB | 1 | 9b2671bbb829… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N200678-001 | 8628799 | 2025-07-13 | Drug product | 2014-01-31 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N200678-001 | 9339472 | 2025-07-13 | Drug product | 2016-05-26 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N200678-002 | 8628799 | 2025-07-13 | Drug product | 2017-03-22 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N200678-002 | 9339472 | 2025-07-13 | Drug product | 2017-03-22 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N200678-003 | 8628799 | 2025-07-13 | Drug product | 2017-03-22 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N200678-003 | 9339472 | 2025-07-13 | Drug product | 2017-03-22 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N200678-001 | 8628799 | 2025-07-13 | Drug product | 2014-01-31 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N200678-001 | 9339472 | 2025-07-13 | Drug product | 2016-05-26 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N200678-002 | 8628799 | 2025-07-13 | Drug product | 2017-03-22 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N200678-002 | 9339472 | 2025-07-13 | Drug product | 2017-03-22 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N200678-003 | 8628799 | 2025-07-13 | Drug product | 2017-03-22 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N200678-003 | 9339472 | 2025-07-13 | Drug product | 2017-03-22 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N200678-001 | 8628799 | 2025-07-13 | Drug product | 2014-01-31 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N200678-001 | 9339472 | 2025-07-13 | Drug product | 2016-05-26 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N200678-002 | 8628799 | 2025-07-13 | Drug product | 2017-03-22 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N200678-002 | 9339472 | 2025-07-13 | Drug product | 2017-03-22 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N200678-003 | 8628799 | 2025-07-13 | Drug product | 2017-03-22 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N200678-003 | 9339472 | 2025-07-13 | Drug product | 2017-03-22 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N200678-001 | 8628799 | 2025-07-13 | Drug product | 2014-01-31 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N200678-001 | 9339472 | 2025-07-13 | Drug product | 2016-05-26 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N200678-002 | 8628799 | 2025-07-13 | Drug product | 2017-03-22 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N200678-002 | 9339472 | 2025-07-13 | Drug product | 2017-03-22 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N200678-003 | 8628799 | 2025-07-13 | Drug product | 2017-03-22 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N200678-003 | 9339472 | 2025-07-13 | Drug product | 2017-03-22 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N200678-001 | 8628799 | 2025-07-13 | Drug product | 2014-01-31 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N200678-001 | 9339472 | 2025-07-13 | Drug product | 2016-05-26 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N200678-002 | 8628799 | 2025-07-13 | Drug product | 2017-03-22 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N200678-002 | 9339472 | 2025-07-13 | Drug product | 2017-03-22 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N200678-003 | 8628799 | 2025-07-13 | Drug product | 2017-03-22 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N200678-003 | 9339472 | 2025-07-13 | Drug product | 2017-03-22 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N200678-001 | 8628799 | 2025-07-13 | Drug product | 2014-01-31 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N200678-001 | 9339472 | 2025-07-13 | Drug product | 2016-05-26 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N200678-002 | 8628799 | 2025-07-13 | Drug product | 2017-03-22 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N200678-002 | 9339472 | 2025-07-13 | Drug product | 2017-03-22 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N200678-003 | 8628799 | 2025-07-13 | Drug product | 2017-03-22 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N200678-003 | 9339472 | 2025-07-13 | Drug product | 2017-03-22 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N200678-001 | 8628799 | 2025-07-13 | Drug product | 2014-01-31 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N200678-001 | 9339472 | 2025-07-13 | Drug product | 2016-05-26 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N200678-002 | 8628799 | 2025-07-13 | Drug product | 2017-03-22 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N200678-002 | 9339472 | 2025-07-13 | Drug product | 2017-03-22 | 5bbf6a4d5a75… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N200678-001 | M-14 | 2027-10-11 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N200678-002 | M-14 | 2027-10-11 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N200678-003 | M-14 | 2027-10-11 | caaa826d4ba7… |
| 2019-12-13 00:20 UTC | 2019-12 | N200678-001 | M-175 | 2019-04-05 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N200678-001 | M-198 | 2020-02-27 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N200678-002 | M-175 | 2019-04-05 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N200678-002 | M-198 | 2020-02-27 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N200678-003 | M-175 | 2019-04-05 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N200678-003 | M-198 | 2020-02-27 | 74a2ff9319b5… |
| 2020-12-22 03:56 UTC | 2020-12 | N200678-001 | M-198 | 2020-02-27 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | N200678-002 | M-198 | 2020-02-27 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | N200678-003 | M-198 | 2020-02-27 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | N200678-001 | M-198 | 2020-02-27 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | N200678-002 | M-198 | 2020-02-27 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | N200678-003 | M-198 | 2020-02-27 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | N200678-001 | M-175 | 2019-04-05 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N200678-001 | M-198 | 2020-02-27 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N200678-002 | M-175 | 2019-04-05 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N200678-002 | M-198 | 2020-02-27 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N200678-003 | M-175 | 2019-04-05 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N200678-003 | M-198 | 2020-02-27 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | N200678-001 | M-175 | 2019-04-05 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N200678-001 | M-198 | 2020-02-27 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N200678-002 | M-175 | 2019-04-05 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N200678-002 | M-198 | 2020-02-27 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N200678-003 | M-175 | 2019-04-05 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N200678-003 | M-198 | 2020-02-27 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | N200678-001 | M-175 | 2019-04-05 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N200678-001 | M-198 | 2020-02-27 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N200678-002 | M-175 | 2019-04-05 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N200678-002 | M-198 | 2020-02-27 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N200678-003 | M-175 | 2019-04-05 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N200678-003 | M-198 | 2020-02-27 | ea99ee380514… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N200678-001 | M-14 | 2027-10-11 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N200678-002 | M-14 | 2027-10-11 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N200678-003 | M-14 | 2027-10-11 | a50c72e98297… |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0310-6125 | KOMBIGLYZE | SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-6125 | KOMBIGLYZE | SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-6125 | KOMBIGLYZE | SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-6125 | KOMBIGLYZE | SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-6125 | KOMBIGLYZE | SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-6125 | KOMBIGLYZE | SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-6125 | KOMBIGLYZE | SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-6135 | KOMBIGLYZE | SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-6135 | KOMBIGLYZE | SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-6135 | KOMBIGLYZE | SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-6135 | KOMBIGLYZE | SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-6135 | KOMBIGLYZE | SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-6135 | KOMBIGLYZE | SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-6135 | KOMBIGLYZE | SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-6145 | KOMBIGLYZE | SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-6145 | KOMBIGLYZE | SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-6145 | KOMBIGLYZE | SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-6145 | KOMBIGLYZE | SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-6145 | KOMBIGLYZE | SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-6145 | KOMBIGLYZE | SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-6145 | KOMBIGLYZE | SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE | AstraZeneca Pharmaceuticals LP | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 79907 | SUPPL | 2024-10-15 |
| 79897 | SUPPL | 2024-10-15 |
| 79896 | SUPPL | 2024-10-15 |
| 59275 | SUPPL | 2019-07-08 |
| 59274 | SUPPL | 2019-07-08 |
| 59214 | SUPPL | 2019-07-02 |
| 56371 | SUPPL | 2018-11-08 |
| 47497 | SUPPL | 2017-03-08 |
| 47360 | SUPPL | 2017-02-28 |
| 46931 | SUPPL | 2017-01-24 |
| 46930 | SUPPL | 2017-01-24 |
| 46921 | SUPPL | 2017-01-18 |
| 46920 | SUPPL | 2017-01-18 |
| 45270 | SUPPL | 2016-09-13 |
| 9844 | SUPPL | 2016-04-07 |
| 18977 | SUPPL | 2015-09-04 |
| 9845 | SUPPL | 2015-09-01 |
| 23474 | ORIG | 2013-06-12 |
| 18976 | SUPPL | 2013-06-04 |
| 32052 | SUPPL | 2013-05-28 |
| 32051 | SUPPL | 2012-04-05 |
| 32050 | SUPPL | 2012-03-13 |
| 32049 | SUPPL | 2012-03-13 |
| 40042 | SUPPL | 2012-03-09 |
| 40041 | SUPPL | 2012-03-09 |
| 9843 | SUPPL | 2011-11-21 |
| 40043 | SUPPL | 2011-11-16 |
| 44825 | ORIG | 2011-09-16 |
| 22835 | ORIG | 2011-09-16 |
| 32048 | ORIG | 2010-11-12 |
| 18975 | ORIG | 2010-11-12 |